Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
PubMed’s failure to display all papers by authors who publish under multiple names “mistreats women,” lawsuit contends

PubMed’s failure to display all papers by authors who publish under multiple names “mistreats women,” lawsuit contends

September 27, 2024
Vol.50 No.36
By Jacquelyn Cobb
Oncology providers, advocates form LGBTQ+ community group at ASCO with focus on research, education, equity
Guest Editorial

Oncology providers, advocates form LGBTQ+ community group at ASCO with focus on research, education, equity

June 21, 2024
Vol.50 No.25
By Don S. Dizon, Chunkit Fung, Paula Chambers Raney, Charles Kamen and Shail Maingi
Clinical Roundup

Among cancer survivors, LGBTQ+ individuals report higher prevalence of chronic health conditions, disabilities, other limitations

June 21, 2024
Vol.50 No.25
Cancer centers, health providers should clearly signal that they welcome LGBTQI+ patients
FreeGuest Editorial

Cancer centers, health providers should clearly signal that they welcome LGBTQI+ patients

June 14, 2024
Vol.50 No.24
By NFN Scout
Don Dizon and NFN Scout on LGBTQ+ patients with cancer
FreeIn the Archives

Don Dizon and NFN Scout on LGBTQ+ patients with cancer

June 07, 2024
Vol.50 No.23
Clinical Roundup

LGBTQ+ cancer report reveals unique stressors, discrimination likely to increase cancer risk

May 31, 2024
Vol.50 No.22
ACS report: 2024 projected new cancer cases top 2 million

ACS report: 2024 projected new cancer cases top 2 million

January 19, 2024
Vol.50 No.03
By Jacquelyn Cobb
More than 500 bills restricting trans medical care threaten LGBTQ+ people with cancer
Free

More than 500 bills restricting trans medical care threaten LGBTQ+ people with cancer

August 11, 2023
Vol.49 No.32
By Alexandria Carolan
SCOTUS decision on denying service to LGBTQ+ people opens doors for discrimination in cancer care

SCOTUS decision on denying service to LGBTQ+ people opens doors for discrimination in cancer care

July 14, 2023
Vol.49 No.28
By Alexandria Carolan
Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities
Guest Editorial

Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

July 07, 2023
Vol.49 No.27
By Kim F. Rhoads, Folakemi T. Odedina, Monica L. Baskin, Vanessa B. Sheppard, Hayley S. Thompson, Kimlin Tam Ashing and Charnita Zeigler-Johnson

Posts navigation

12Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis
  • Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
  • GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
    Mainstream epidemiologists beg to differ
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
    Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account